RT @UMCPC_official: Aspirin can reduce bowel cancer risk by up to 25%. In our "Should I Take Aspirin?" Trial #SITA, a decision aid increase…
Aspirin can reduce bowel cancer risk by up to 25%. In our "Should I Take Aspirin?" Trial #SITA, a decision aid increased discussions between patients and their GPs by over 30%. Read more below:⬇️⬇️ https://t.co/e3qCBBhpgq https://t.co/pO930Ldmbn
An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial https://t.co/HcabH2cApL
New article: An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial https://t.co/BLoYERAsgP #colorectalcancer #oncology